Tags

Type your tag names separated by a space and hit enter

Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.
Pediatrics. 1995 Oct; 96(4 Pt 1):758-64.Ped

Abstract

Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by a throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) remains the treatment of choice, because it is cost effective, has a narrow spectrum of activity, has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. Various macrolides, oral cephalosporins, and other beta-lactam agents are acceptable alternatives, particularly in penicillin-allergic individuals. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The duration of prophylaxis depends on the number of previous attacks, the time lapsed since the last attack, the risk of exposure to streptococcal infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or erythromycin are acceptable alternatives in penicillin-allergic individuals. This report is an update of a 1988 statement by this committee. It expands on the previous statement, includes more recent therapeutic modalities, and makes more specific recommendations for the duration of secondary prophylaxis.

Authors+Show Affiliations

American Heart Association, Dallas, TX 75231, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Guideline
Journal Article
Practice Guideline

Language

eng

PubMed ID

7567345

Citation

Dajani, A, et al. "Treatment of Acute Streptococcal Pharyngitis and Prevention of Rheumatic Fever: a Statement for Health Professionals. Committee On Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council On Cardiovascular Disease in the Young, the American Heart Association." Pediatrics, vol. 96, no. 4 Pt 1, 1995, pp. 758-64.
Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96(4 Pt 1):758-64.
Dajani, A., Taubert, K., Ferrieri, P., Peter, G., & Shulman, S. (1995). Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics, 96(4 Pt 1), 758-64.
Dajani A, et al. Treatment of Acute Streptococcal Pharyngitis and Prevention of Rheumatic Fever: a Statement for Health Professionals. Committee On Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council On Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96(4 Pt 1):758-64. PubMed PMID: 7567345.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. AU - Dajani,A, AU - Taubert,K, AU - Ferrieri,P, AU - Peter,G, AU - Shulman,S, PY - 1995/10/1/pubmed PY - 1995/10/1/medline PY - 1995/10/1/entrez SP - 758 EP - 64 JF - Pediatrics JO - Pediatrics VL - 96 IS - 4 Pt 1 N2 - Primary prevention of acute rheumatic fever is accomplished by proper identification and adequate antibiotic treatment of group A beta-hemolytic streptococcal (GAS) tonsillopharyngitis. Diagnosis of GAS pharyngitis is best accomplished by a throat culture. Penicillin (either oral penicillin V or injectable benzathine penicillin) remains the treatment of choice, because it is cost effective, has a narrow spectrum of activity, has long-standing proven efficacy, and GAS resistant to penicillin have not been documented. Various macrolides, oral cephalosporins, and other beta-lactam agents are acceptable alternatives, particularly in penicillin-allergic individuals. The individual who has had an attack of rheumatic fever is at very high risk of developing recurrences after subsequent GAS pharyngitis and needs continuous antimicrobial prophylaxis to prevent such recurrences (secondary prevention). The duration of prophylaxis depends on the number of previous attacks, the time lapsed since the last attack, the risk of exposure to streptococcal infections, the age of the patient, and the presence or absence of cardiac involvement. Penicillin is again the agent of choice for secondary prophylaxis, but sulfadiazine or erythromycin are acceptable alternatives in penicillin-allergic individuals. This report is an update of a 1988 statement by this committee. It expands on the previous statement, includes more recent therapeutic modalities, and makes more specific recommendations for the duration of secondary prophylaxis. SN - 0031-4005 UR - https://www.unboundmedicine.com/medline/citation/7567345/Treatment_of_acute_streptococcal_pharyngitis_and_prevention_of_rheumatic_fever:_a_statement_for_health_professionals__Committee_on_Rheumatic_Fever_Endocarditis_and_Kawasaki_Disease_of_the_Council_on_Cardiovascular_Disease_in_the_Young_the_American_Heart_Association_ L2 - http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=7567345 DB - PRIME DP - Unbound Medicine ER -